Rolipram Improves Outcome in a Rat Model of Infant Sepsis-Induced Cardiorenal Syndrome
While the mortality rate associated with sepsis in children has fallen over the years, it still remains unacceptably high. The development of both acute cardiac dysfunction and acute kidney injury during severe sepsis is categorized as type 5 cardiorenal syndrome (CRS) and is poorly understood in in...
Saved in:
Main Authors: | Clark R. Sims (Author), Sharda P. Singh (Author), Shengyu Mu (Author), Neriman Gokden (Author), Dala Zakaria (Author), Trung C. Nguyen (Author), Philip R. Mayeux (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2017-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Novel Liposomal Rolipram Formulation for Clinical Application to Reduce Emesis
by: Gobejishvili L, et al.
Published: (2022) -
Rolipram, a PDE4 Inhibitor, Enhances the Inotropic Effect of Rat Heart by Activating SERCA2a
by: Huili Huang, et al.
Published: (2019) -
Oxidative Stress in Cardiorenal System
by: Carlos R. Tirapelli, et al.
Published: (2024) -
Cardiorenal Syndrome Type 5 in Sepsis: Role of Endotoxin in Cell Death Pathways and Inflammation
by: Grazia Maria Virzì, et al.
Published: (2016) -
Cardiorenal and hepatorenal syndrome
by: Anand Bhutada, et al.
Published: (2018)